American Portfolios Advisors Editas Medicine, Inc. Transaction History

American Portfolios Advisors

  • $2.36 Trillion
  • Q3 2022

A detailed history of American Portfolios Advisors transactions in Editas Medicine, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 867 shares of EDIT stock, worth $1,135. This represents 0.0% of its overall portfolio holdings.

Number of Shares
867
Holding current value
$1,135
% of portfolio
0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023
BUY
$12.16 - $19.42 $10,542 - $16,837
867 New
867 $10.6 Million
Q2 2022

Mar 20, 2023
BUY
$9.99 - $21.35 $2,827 - $6,042
283 Added 32.64%
1,150 $13.6 Million
Q1 2022

Mar 21, 2023
BUY
$14.08 - $27.63 $9,968 - $19,562
708 Added 81.66%
1,575 $30 Million
Q4 2021

Mar 21, 2023
BUY
$26.55 - $40.57 $192,407 - $294,010
7,247 Added 835.87%
8,114 $215 Million
Q3 2021

Mar 22, 2023
BUY
$39.27 - $72.94 $518,992 - $963,975
13,216 Added 1524.34%
14,083 $579 Million
Q2 2021

Mar 22, 2023
BUY
$31.29 - $56.64 $430,425 - $779,139
13,756 Added 1586.62%
14,623 $828 Million
Q1 2021

Mar 22, 2023
BUY
$39.71 - $90.58 $567,138 - $1.29 Million
14,282 Added 1647.29%
15,149 $636 Million
Q4 2020

Mar 22, 2023
BUY
$27.07 - $84.35 $323,621 - $1.01 Million
11,955 Added 1378.89%
12,822 $899 Million
Q3 2020

Mar 22, 2023
BUY
$28.06 - $37.16 $192,154 - $254,471
6,848 Added 789.85%
7,715 $216 Million
Q2 2020

Mar 24, 2023
BUY
$18.5 - $34.34 $41,088 - $76,269
2,221 Added 159.55%
3,613 $107 Million
Q1 2020

Mar 24, 2023
BUY
$14.88 - $32.78 $7,812 - $17,209
525 Added 60.55%
1,392 $27.6 Million
Q4 2019

Mar 24, 2023
SELL
$19.49 - $32.63 $2,631 - $4,405
-135 Reduced 15.57%
732 $21.7 Million
Q2 2019

Mar 24, 2023
SELL
$20.48 - $27.76 $2,764 - $3,747
-135 Reduced 15.57%
732 $18.1 Million
Q1 2019

Mar 24, 2023
BUY
$19.43 - $26.41 $3,886 - $5,282
200 Added 37.59%
732 $17.9 Million
Q4 2018

Mar 24, 2023
SELL
$18.19 - $31.79 $2,146 - $3,751
-118 Reduced 18.15%
532 $12.1 Million
Q3 2018

Mar 24, 2023
SELL
$27.65 - $38.39 $6,000 - $8,330
-217 Reduced 25.03%
650 $20.7 Million
Q2 2018

Mar 24, 2023
BUY
$31.4 - $41.01 $12,560 - $16,404
400 Added 800.0%
450 $16.1 Million
Q1 2018

Mar 24, 2023
SELL
$29.84 - $44.08 $24,379 - $36,013
-817 Reduced 94.23%
50 $1.66 Million

Others Institutions Holding EDIT

# of Institutions
248
Shares Held
57M
Call Options Held
410K
Put Options Held
394K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $90M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email